Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 14, 2020

View Archived Issues

AbbVie conducts phase Ib study of eftozanermin alfa in relapsed or refractory multiple myeloma

Enrollment ongoing in phase II study of HTD-1801 in primary biliary cholangitis

Novel potent PI3Kdelta inhibitors that target two different mechanisms of isoform selectivity

AK-002 reduces GI eosinophils and symptoms in eosinophilic gastritis/duodenitis: phase I results

Regenerative approach shows promise in pediatric heart disease

hAd5-COVID-19 vaccine candidate protects nasal and lung airways in nonhuman primates

Preliminary clinical data for proxalutamide in COVID-19

ProTrans-Repeat meets its primary safety endpoint at 24 months

Leqvio approved in Europe for the treatment of hypercholesterolemia or mixed dyslipidemia

Tychan to initiate phase III study of TY-027 in patients with COVID-19

PureTech initiates phase I study of LYT-200 in metastatic solid tumors

Phase I data presented for CTA-101 in patients with R/R B-cell ALL

TAK-573 shows clinical activity in relapsed/refractory multiple myeloma in first-in-human study

Exploratory study suggests ZYN-002 reduces seizures in children with encephalopathies

Hinova Pharmaceuticals patents new PROTACs

Cadila Healthcare discloses new compounds for tuberculosis

Italian researchers identify new compounds for HBV infection

Boryung Pharmaceutical describes new PI3Kdelta and/or DNA-PK inhibitors

Suzhou Ribo Life Science patents FXI-targeting siRNA

MET no better than EMT for cancer metastases

Amarin reports data on Vascepa in COVID-19 outpatients

Aerpio announces phase II data on razuprotafib in glaucoma

Akari releases long-term data on nomacopan in paroxysmal nocturnal hemoglobinuria

Ultimovacs reports 5-year survival data from phase I trial of UV-1 in metastatic melanoma

Phase III study of ruxolitinib in COVID-19 does not meet primary endpoint

PMD-026 shows safety and initial signs of activity in metastatic breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...